Liu Q - Search Results

1

Cell Cycle Regulation in Treatment of Breast Cancer.

Cai Z, Liu Q. Cai Z, et al. Among authors: liu q. Adv Exp Med Biol. 2017;1026:251-270. doi: 10.1007/978-981-10-6020-5_12. Adv Exp Med Biol. 2017. PMID: 29282688 Review.

2

Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.

Zhou FF, Yan M, Guo GF, Wang F, Qiu HJ, Zheng FM, Zhang Y, Liu Q, Zhu XF, Xia LP. Zhou FF, et al. Among authors: liu q. Med Oncol. 2011 Dec;28(4):1302-7. doi: 10.1007/s12032-010-9630-0. Epub 2010 Jul 22. Med Oncol. 2011. PMID: 20652449

3

Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.

Yao YD, Sun TM, Huang SY, Dou S, Lin L, Chen JN, Ruan JB, Mao CQ, Yu FY, Zeng MS, Zang JY, Liu Q, Su FX, Zhang P, Lieberman J, Wang J, Song E. Yao YD, et al. Among authors: liu q. Sci Transl Med. 2012 Apr 18;4(130):130ra48. doi: 10.1126/scitranslmed.3003601. Sci Transl Med. 2012. PMID: 22517885

4

What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis.

Zhao J, Liu J, Chen K, Li S, Wang Y, Yang Y, Deng H, Jia W, Rao N, Liu Q, Su F. Zhao J, et al. Among authors: liu j, liu q. Breast Cancer Res Treat. 2014 May;145(1):113-28. doi: 10.1007/s10549-014-2914-x. Epub 2014 Mar 27. Breast Cancer Res Treat. 2014. PMID: 24671358

5

E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.

Chu J, Zhu Y, Liu Y, Sun L, Lv X, Wu Y, Hu P, Su F, Gong C, Song E, Liu B, Liu Q. Chu J, et al. Among authors: liu y, liu b, liu q. Oncotarget. 2015 Oct 13;6(31):31944-57. doi: 10.18632/oncotarget.5128. Oncotarget. 2015. PMID: 26397135 Free PMC article.

6

Noncoding RNAs in Cancer Immunology.

Li Q, Liu Q. Li Q, et al. Among authors: liu q. Adv Exp Med Biol. 2016;927:243-64. doi: 10.1007/978-981-10-1498-7_9. Adv Exp Med Biol. 2016. PMID: 27376738 Review.

7

Comparison of the Therapeutic Efficacy of the Early and the Delayed Use of Vinorelbine-Based Regimens for Patients with Advanced Breast Cancer.

Wang Y, Liu J, Jia W, Li S, Rao N, Su F, Liu Q, Yao H. Wang Y, et al. Among authors: liu j, liu q. Chemotherapy. 2017;62(1):71-79. doi: 10.1159/000448472. Epub 2016 Sep 21. Chemotherapy. 2017. PMID: 27648841

8

Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.

Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, Huang W, Han S, Zhang T, Wang Z, Jiao B, Song S, Wang H, Chen L, Zhou D, Liu Q, Ren R, Zhang J, Deng X. Jiang J, et al. Among authors: liu q. Cancer Res. 2017 Jan 1;77(1):175-186. doi: 10.1158/0008-5472.CAN-16-1038. Epub 2016 Oct 10. Cancer Res. 2017. PMID: 27758886

9

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.

Zhu Y, Liu Y, Zhang C, Chu J, Wu Y, Li Y, Liu J, Li Q, Li S, Shi Q, Jin L, Zhao J, Yin D, Efroni S, Su F, Yao H, Song E, Liu Q. Zhu Y, et al. Among authors: liu j, liu y, liu q. Nat Commun. 2018 Apr 23;9(1):1595. doi: 10.1038/s41467-018-03951-0. Nat Commun. 2018. PMID: 29686231 Free PMC article.

10

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients.

Li H, Liu J, Chen J, Wang H, Yang L, Chen F, Fan S, Wang J, Shao B, Yin D, Zeng M, Li M, Li J, Su F, Liu Q, Yao H, Su S, Song E. Li H, et al. Among authors: liu j, liu q. Nat Commun. 2018 Apr 24;9(1):1614. doi: 10.1038/s41467-018-03537-w. Nat Commun. 2018. PMID: 29691399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,966 results

Search Page

Filters